Cover Image

Editorial: Cell cycle control as a new therapeutic approach for SARS-CoV-2 infection

Saved in:

Bibliographic Details
Main Authors:	Roberta Rizzo (Author), Francesca Caccuri (Author), Giuseppe Valacchi (Author), Giorgio Zauli (Author)
Format:	Book
Published:	Frontiers Media S.A., 2023-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cell cycle block by p53 activation reduces SARS-CoV-2 release in infected alveolar basal epithelial A549-hACE2 cells
by: Giada Lodi, et al.
Published: (2022)

Editorial: SARS-CoV-2 in water
by: Eiji Haramoto, et al.
Published: (2022)

p53/NF-kB Balance in SARS-CoV-2 Infection: From OMICs, Genomics and Pharmacogenomics Insights to Tailored Therapeutic Perspectives (COVIDomics)
by: Daniela Milani, et al.
Published: (2022)

SARS-CoV-2 and the nervous system: review on pathogenesis of nervous system SARS-CoV-2 damage
by: Bai, Francesca
Published: (2021)

SARS-CoV-2 virus: origin, structure and replication cycle
by: Katarzyna Kuczyńska, et al.
Published: (2021)

New perspective towards therapeutic regimen against SARS-CoV-2 infection
by: Vartika Srivastava, et al.
Published: (2021)

Morphea after SARS-CoV2 vaccine
by: Giovanni Paolino, et al.
Published: (2023)

A Dynamic and Effective Peptide-Based Strategy for Promptly Addressing Emerging SARS-CoV-2 Variants of Concern
by: Michela Murdocca, et al.
Published: (2024)

Development of an In Vitro Model of SARS-CoV-Induced Acute Lung Injury for Studying New Therapeutic Approaches
by: Yulia A. Shevtsova, et al.
Published: (2022)

Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19
by: Khan Sharun, et al.
Published: (2020)

Sensitivity of SARS-CoV-2 Detection With Nasopharyngeal Swabs
by: Bianca Clerici, et al.
Published: (2021)

Antiviral Therapeutic Approaches for SARS-CoV-2 Infection: A Systematic Review
by: Victoria Gil Martínez, et al.
Published: (2021)

Editorial: The Mechanisms of Action of Anti-SARS-CoV-2 Drugs
by: Wu Zhong, et al.
Published: (2022)

Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 helicase inhibitors: a systematic review of in vitro studies
by: Nimer Mehyar
Published: (2023)

Trends in MERS-CoV, SARS-CoV, and SARS-CoV-2 (COVID-19) Diagnosis Strategies: A Patent Review
by: José Adão Carvalho Nascimento Junior, et al.
Published: (2020)

Comparison of the Characteristics of Cytokine Storm and Immune Response Induced by SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections
by: Liu T, et al.
Published: (2021)

New Coronavirus COVID-19 (SARS-CoV-2)
by: O. V. Shamsheva
Published: (2020)

SARS-CoV-2 and Swabs: Disease Severity and the Numbers of Cycles of Gene Amplification, Single Center Experience
by: Raffaele Falsaperla, et al.
Published: (2023)

Product of natural evolution (SARS, MERS, and SARS-CoV-2); deadly diseases, from SARS to SARS-CoV-2
by: Mohamad Hesam Shahrajabian, et al.
Published: (2021)

Cycle Threshold Values in the Context of Multiple RT-PCR Testing for SARS-CoV-2
by: Romero-Alvarez D, et al.
Published: (2021)

New Thiazolidine-4-One Derivatives as SARS-CoV-2 Main Protease Inhibitors
by: Antonella Messore, et al.
Published: (2024)

Therapeutic implications in patients with subacute thyroiditis in the SARS-CoV-2 era
by: Katrin Henke, et al.
Published: (2022)

Potential and Possible Therapeutic Effects of Melatonin on SARS-CoV-2 Infection
by: Evgeny Shchetinin, et al.
Published: (2022)

Anti-SARS-CoV-2 Natural Products as Potentially Therapeutic Agents
by: Cheorl-Ho Kim
Published: (2021)

Rapid Serological Assays and SARS-CoV-2 Real-Time Polymerase Chain Reaction Assays for the Detection of SARS-CoV-2: Comparative Study
by: Paradiso, Angelo Virgilio, et al.
Published: (2020)

Corrigendum: Editorial: The mechanisms of action of anti-SARS-CoV-2 drugs
by: Wu Zhong, et al.
Published: (2022)

New Approaches and Repurposed Antiviral Drugs for the Treatment of the SARS-CoV-2 Infection
by: Luana Vittoria Bauso, et al.
Published: (2021)

Computational study of the therapeutic potentials of a new series of imidazole derivatives against SARS-CoV-2
by: Titilayo O. Johnson, et al.
Published: (2021)

Anti-SARS-CoV Natural Products With the Potential to Inhibit SARS-CoV-2 (COVID-19)
by: Surjeet Verma, et al.
Published: (2020)

On the SARS-CoV-2 Variants
by: Fabio Scarpa, et al.
Published: (2024)

Are the new SARS-CoV-2 variants resistant against the vaccine?
by: Mohnad Abdalla, et al.
Published: (2021)

CoV-Seq, a New Tool for SARS-CoV-2 Genome Analysis and Visualization: Development and Usability Study
by: Liu, Boxiang, et al.
Published: (2020)

SARS-CoV-2 induced IgA vasculitis confirmed with SARS-CoV-2 tissue testing
by: Ahmed N. Ansari, MD, et al.
Published: (2024)

Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1 antibodies
by: Romain Rouet, et al.
Published: (2021)

Rapid Cycle Implementation and Retrospective Evaluation of a SARS-CoV-2 Checklist in Labor and Delivery
by: Liana Zucco, et al.
Published: (2021)

Bromelain: A potential therapeutic application in SARS-CoV-2 infected patients
by: Serkan Sayıner, et al.
Published: (2021)

Therapeutic Targeting of Innate Immune Receptors Against SARS-CoV-2 Infection
by: Mariya Farooq, et al.
Published: (2022)

Redox Status Is the Mainstay of SARS-CoV-2 and Host for Producing Therapeutic Opportunities
by: Anand Thirupathi, et al.
Published: (2022)

Carbon-based nanomaterials against SARS-CoV-2: Therapeutic and diagnostic applications
by: Sepideh Ahmadi, et al.
Published: (2023)

Targeting SARS-CoV-2 Variants with Nucleic Acid Therapeutic Nanoparticle Conjugates
by: Hanah F. Huber, et al.
Published: (2021)